P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Veterinary Pharmacology and Therapeutics

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1365-2885.2007.00808.XPMID 17217397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery.

  2006cited by this paper
• ABC A-subfamily transporters: structure, function and disease.

  2006cited by this paper
• Does inhibition of P-glycoprotein lead to drug-drug interactions?

  2005cited by this paper
• Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

  2005cited by this paper
• Role of soybean oil fat emulsion in the prevention of hepatic xenobiotic transporter mRNA up- and down-regulation induced by overdose of fat-free total parenteral nutrition in infant rats.

  2005cited by this paper
• Multidrug resistance in human cancer

  2005cited by this paper
• Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.

  2005cited by this paper
• Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

  2005cited by this paper
• Cholesterol and plant sterol absorption: recent insights.

  2005cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Therapeutic implications of the MDR-1 gene.

  2004cited by this paper
• Ex Situ Inhibition of Hepatic Uptake and Efflux Significantly Changes Metabolism: Hepatic Enzyme-Transporter Interplay

  2004cited by this paper
• Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

  2003cited by this paper
• Role of P-Glycoprotein in Pharmacokinetics

  2003cited by this paper
• Pharmaceutical antibiotic compounds in soils – a review

  2003cited by this paper
• The role of ABC transporters in clinical practice.

  2003cited by this paper
• Factors Affecting the Disposition of Ivermectin in the Target Species

  2002cited by this paper
• Toxicity of Tetracyclines and Tetracycline Degradation Products to Environmentally Relevant Bacteria, Including Selected Tetracycline-Resistant Bacteria

  2002cited by this paper
• Antibiotic resistance in soil and water environments

  2002cited by this paper
• Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry.

  2002cited by this paper
• Role of transport proteins in drug absorption, distribution and excretion

  2001cited by this paper
• Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

  2001cited by this paper
• Caco-2 monolayers in experimental and theoretical predictions of drug transport.

  2001cited by this paper
• Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.

  2000cited by this paper
• The effects of pH and mixed solvent systems on the solubility of oxytetracycline.

  1999cited by this paper
• Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.

  1997cited by this paper
• Analysis of Drug Permeation Across Caco-2 Monolayer: Implication for Predicting In Vivo Drug Absorption

  1997cited by this paper
• Bioavailability of oxytetracycline, tetracycline and chlortetracycline after oral administration to fed and fasted pigs.

  1996cited by this paper
• Functional expression of the human MDR1 gene in Escherichia coli.

  1996cited by this paper
• Functional Expression of the HumanMDR1Gene inEscherichia coli

  1996cited by this paper
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

  1995cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.

  1993cited by this paper
• Multidrug resistance in human cancer.

  1992cited by this paper
• Plasma levels of oxytetracycline, doxycycline, and minocycline in pigs after oral administration in feed.

  1991cited by this paper
• Pharmacokinetics of oxytetracycline in the turkey: evaluation of biliary and urinary excretion.

  1989cited by this paper
• Reduced cytotoxicity of tetracyclines to a multi-drug resistant human cell line.

  1988cited by this paper
• Pharmacokinetics and renal clearance of oxytetracycline in piglets following intravenous and oral administration.

  1986cited by this paper
• Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

  1985cited by this paper
• The influence of food on the absorption of antimicrobial agents.

  1982cited by this paper

• Assessment of clinically relevant drugs as feline P-glycoprotein substrates

  2025cites this paper
• P-gp/BCRP efflux and intestinal metabolism limit tigecycline exposure: Effects of elacridar and voriconazole in mice.

  2025cites this paper
• Drug Transporters and Metabolizing Enzymes in Antimicrobial Drug Pharmacokinetics: Mechanisms, Drug–Drug Interactions, and Clinical Implications

  2025cites this paper
• Application of eprinomectin-containing parasiticides at label doses causes neurological toxicosis in cats homozygous for ABCB11930_1931del TC.

  2024cites this paper
• Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker.

  2023cites this paper
• Tigecycline Absorption Improved by Selected Excipients

  2023cites this paper
• A physiologically based pharmacokinetic (PBPK) model exploring the blood-milk barrier in lactating species - A case study with oxytetracycline administered to dairy cows and goats.

  2022cites this paper
• Treatment and Protective Effects of Metalloproteinase Inhibitors Alone and in Combination with N-Acetyl Cysteine Plus Vitamin E in Rats Exposed to Aflatoxin B1.

  2021cites this paper
• Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs

  2021cites this paper
• Interaction of swine organic anion transporting polypeptide 1a2 with tetracycline, macrolide and β-lactam antibiotics.

  2019cites this paper
• Pharmacokinetics of tigecycline in turkeys following different routes of administration

  2018cites this paper
• Blood–Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies

  2017cites this paper
• P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease

  2017cites this paper
• Physiological scaling factors and mechanistic models for prediction of renal clearance from in vitro data

  2016cites this paper
• Multi-Drug Resistance Transporters and a Mechanism-Based Strategy for Assessing Risks of Pesticide Combinations to Honey Bees

  2016cites this paper
• Pharmacokinetics of oxytetracycline in broiler chickens following different routes of administration.

  2016cites this paper
• The Role of Drug Transporters in the Pharmacokinetics of Antibiotics.

  2016cites this paper
• Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.

  2015cites this paper
• Intrabronchial Microdialysis: Effects of Probe Localization on Tissue Trauma and Drug Penetration into the Pulmonary Epithelial Lining Fluid

  2015cites this paper
• Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites.

  2014cites this paper
• 5 Transporters in the Blood-Brain Barrier

  2012cites this paper
• In vivo and ex vivo assessment of the interaction between ivermectin and danofloxacin in sheep.

  2012cites this paper
• P-glycoprotein (P-gp) in the monogonont rotifer, Brachionus koreanus: molecular characterization and expression in response to pharmaceuticals.

  2012cites this paper
• A novel method using confocal laser scanning microscopy for sensitive measurement of P‐glycoprotein‐mediated transport activity in Caco‐2 cells

  2011cites this paper
• Transporters in the Blood-Brain Barrier

  2011cites this paper
• P-glycoprotein is functionally expressed in the placenta-derived bovine caruncular epithelial cell line 1 (BCEC-1).

  2011cites this paper
• Killing Them with Kindness? In-Hive Medications May Inhibit Xenobiotic Efflux Transporters and Endanger Honey Bees

  2011cites this paper
• Transporters in the brain endothelial barrier.

  2010cites this paper
• Tumor necrosis factor alpha increases P‐glycoprotein expression in a BME‐UV in vitro model of mammary epithelial cells

  2010cites this paper
• Expression and function of drug transporters in an in vitro model of the mammary epithelial barrier (BME-UV)

  2010cites this paper
• Mechanisms of the Penetration of Blood-Borne Substances into the Brain

  2009cites this paper
• A Novel Nanocapsule Delivery System to Overcome Intestinal Degradation and Drug Transport Limited Absorption of P-glycoprotein Substrate Drugs

  2008influential citation
• A ROLE OF P-GLYCOPROTEIN IN MODULATION OF ANTIBIOTIC PHARMACOKINETICS

  2008cites this paper
• Implications of ABC transporters on the disposition of typical veterinary medicinal products.

  2008cites this paper
• Molecular anatomy of the brain endothelial barrier: an overview of the distributional features.

  2007cites this paper